1. Home
  2. KVHI vs CRDL Comparison

KVHI vs CRDL Comparison

Compare KVHI & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KVHI
  • CRDL
  • Stock Information
  • Founded
  • KVHI 1978
  • CRDL 2017
  • Country
  • KVHI United States
  • CRDL Canada
  • Employees
  • KVHI N/A
  • CRDL N/A
  • Industry
  • KVHI Radio And Television Broadcasting And Communications Equipment
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KVHI Technology
  • CRDL Health Care
  • Exchange
  • KVHI Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • KVHI 105.7M
  • CRDL 102.0M
  • IPO Year
  • KVHI 1996
  • CRDL N/A
  • Fundamental
  • Price
  • KVHI $5.30
  • CRDL $0.96
  • Analyst Decision
  • KVHI
  • CRDL Strong Buy
  • Analyst Count
  • KVHI 0
  • CRDL 3
  • Target Price
  • KVHI N/A
  • CRDL $9.00
  • AVG Volume (30 Days)
  • KVHI 33.9K
  • CRDL 241.3K
  • Earning Date
  • KVHI 03-06-2025
  • CRDL 05-13-2025
  • Dividend Yield
  • KVHI N/A
  • CRDL N/A
  • EPS Growth
  • KVHI N/A
  • CRDL N/A
  • EPS
  • KVHI N/A
  • CRDL N/A
  • Revenue
  • KVHI $113,828,000.00
  • CRDL N/A
  • Revenue This Year
  • KVHI N/A
  • CRDL N/A
  • Revenue Next Year
  • KVHI N/A
  • CRDL N/A
  • P/E Ratio
  • KVHI N/A
  • CRDL N/A
  • Revenue Growth
  • KVHI N/A
  • CRDL N/A
  • 52 Week Low
  • KVHI $4.17
  • CRDL $0.88
  • 52 Week High
  • KVHI $6.16
  • CRDL $3.12
  • Technical
  • Relative Strength Index (RSI)
  • KVHI 57.91
  • CRDL 34.30
  • Support Level
  • KVHI $5.17
  • CRDL $1.10
  • Resistance Level
  • KVHI $5.41
  • CRDL $1.18
  • Average True Range (ATR)
  • KVHI 0.27
  • CRDL 0.09
  • MACD
  • KVHI 0.07
  • CRDL -0.01
  • Stochastic Oscillator
  • KVHI 100.00
  • CRDL 22.95

About KVHI KVH Industries Inc.

KVH Industries Inc provide integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. The Company operates in a number of geographic areas, including internationally. The Revenues are generated from international locations, mainly consisting of Singapore, Canada, European Union countries and other European countries, countries in Africa, Asia/Pacific and the Middle East, and India.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: